APOE and triple-A syndrome: Daugherty et al. showed that selective blockade of AT1 signaling with Losartan attenuated AAA formation in the Angiotensin II-infused apoE−/− mouse model, but blockade of AT2 signalling resulted in more severe atherosclerosis and aneurysmal disease [77].